Conference abstractPublished 2018
An account of melatonin modified release in gastrointestinal fluids
National and Kapodistrian University of Athens, Greece
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Melatonin (N-acetyl-5-methoxytryptamine, MLT), a hormone synthesized by the pineal gland and released at night, has a regulatory role on sleep in humans. The effect of fast-release formulations on sleep initiation may come from the high amount of melatonin released immediately after administration, while the benefit of the modified release systems comes from the release of melatonin in small dosages during the entire night. A series of matrix tablets was prepared and tested with respect to their ability to release the hormone melatonin in a controlled manner, in order to prevent sleep onset and sleep maintenance dysfunctions. Besides the active ingredient, the tablets were comprised of combinations of the following: HPMC K 15M, low viscosity sodium alginate, microcrystalline cellulose (Avicel PH 102), polyvinylpyrrolidone, lactose, magnesium stearate. The controlled release studies were conducted in two aqueous dissolution media at pH 1.2 and 7.4. The dissolution experiments were carried out in a USP XXIII dissolution apparatus for ten hours (the first three hours at pH 1.2 and the rest seven at pH 7.4). The aim of the current work was to extend our previous studies on the chronobiotic hormone melatonin controlled release, by comparing its release from many solid formulations.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Sciences & Emerging Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Vlachou M”
